Rare but Serious: Ibrutinib Induced Liver Failure
Open Access
- 22 November 2019
- journal article
- case report
- Published by Wiley in HemaSphere
- Vol. 3 (6) , e307
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- How I manage ibrutinib intolerance and complications in patients with chronic lymphocytic leukemiaBlood, 2019
- Ibrutinib-induced acute liver failureLeukemia & Lymphoma, 2017
- Ibrutinib‐induced severe liver injuryClinical Case Reports, 2017
- Occult HBV reactivation induced by ibrutinib treatment: a case report.2015
- Model for end-stage liver disease score and MELD exceptions: 15 years laterHepatology International, 2015
- Hepatotoxicity of Tyrosine Kinase Inhibitors: Clinical and Regulatory PerspectivesDrug Safety, 2013